相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Long-term cardiovascular outcomes of COVID-19
Yan Xie et al.
NATURE MEDICINE (2022)
Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
A. Jayk Bernal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Redox-dependent internalization of the purinergic P2Y6 receptor limits colitis progression
Kazuhiro Nishiyama et al.
SCIENCE SIGNALING (2022)
Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater
Davida S. Smyth et al.
NATURE COMMUNICATIONS (2022)
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
Gilmar Reis et al.
LANCET GLOBAL HEALTH (2022)
Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications
Shubham Agarwal et al.
CARDIOVASCULAR DRUGS AND THERAPY (2021)
Spike mutation D614G alters SARS-CoV-2 fitness
Jessica A. Plante et al.
NATURE (2021)
Risk factors for severe and critically ill COVID-19 patients: A review
Ya-dong Gao et al.
ALLERGY (2021)
Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system
Man Lung Yeung et al.
CELL (2021)
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
Salim S. Abdool Karim et al.
LANCET (2021)
Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro
Jiayu Lu et al.
LIFE SCIENCES (2021)
Detection of a SARS-CoV-2 variant of concern in South Africa
Houriiyah Tegally et al.
NATURE (2021)
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies et al.
SCIENCE (2021)
Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2021)
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
Matan Levine-Tiefenbrun et al.
NATURE MEDICINE (2021)
Post-acute COVID-19 syndrome
Ani Nalbandian et al.
NATURE MEDICINE (2021)
SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19
Juan A. Perez-Bermejo et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms
Bruno Silva Andrade et al.
VIRUSES-BASEL (2021)
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England
Ross J. Harris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Drug repurposing against coronavirus disease 2019 (COVID-19): A review
Lianxiang Luo et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2021)
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil
Carolina Kymie Vasques Nonaka et al.
EMERGING INFECTIOUS DISEASES (2021)
A novel coronavirus outbreak of global health concern
Chen Wang et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
Bolin Wang et al.
AGING-US (2020)
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
L. Zhang et al.
ANNALS OF ONCOLOGY (2020)
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Markus Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
Liang Chen et al.
CARDIOVASCULAR RESEARCH (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Myocardial localization of coronavirus in COVID-19 cardiogenic shock
Guido Tavazzi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic
Satyajit Tripathy et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Xiaochen Li et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
Meng-Yuan Li et al.
INFECTIOUS DISEASES OF POVERTY (2020)
Potential Effects of Coronaviruses on the Cardiovascular System A Review
Mohammad Madjid et al.
JAMA CARDIOLOGY (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
Multiorgan and Renal Tropism of SARS-CoV-2
Victor G. Puelles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients
Tianxiao Liu et al.
PHARMACOLOGY & THERAPEUTICS (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system
Ryosuke Fujita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
ACE2, Much More Than Just a Receptor for SARS-COV-2
Lobelia Samavati et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases
Diana Lindner et al.
JAMA CARDIOLOGY (2020)
ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19
Bruna G. G. Pinto et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
The protein expression profile of ACE2 in human tissues
Feria Hikmet et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
SARS-CoV-2 infects and induces cytotoxic effacts in human cardiomyocytes
Denisa Bojkova et al.
CARDIOVASCULAR RESEARCH (2020)
Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2
Yuan-Lin Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Drug repurposing approach to fight COVID-19
Thakur Uttam Singh et al.
PHARMACOLOGICAL REPORTS (2020)
Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
Khan Sharun et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection
Pranesh Padmanabhan et al.
PLOS COMPUTATIONAL BIOLOGY (2020)
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic
Giulio Cavalli et al.
FRONTIERS IN PHARMACOLOGY (2020)
Challenges for Drug Repurposing in the COVID-19 Pandemic Era
Janet Sultana et al.
FRONTIERS IN PHARMACOLOGY (2020)
Clinical trials on drug repositioning for COVID-19 treatment
Sandro G. Viveiros Rosa et al.
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH (2020)
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Egor P. Tchesnokov et al.
VIRUSES-BASEL (2019)
Ibudilast attenuates doxorubicin-induced cytotoxicity by suppressing formation of TRPC3 channel and NADPH oxidase 2 protein complexes
Kazuhiro Nishiyama et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Depolysulfidation of Drp1 induced by low-dose methylmercury exposure increases cardiac vulnerability to hemodynamic overload
Akiyuki Nishimura et al.
SCIENCE SIGNALING (2019)
TRPC3-Nox2 axis mediates nutritional deficiency-induced cardiomyocyte atrophy
Suhaini Binti Sudi et al.
SCIENTIFIC REPORTS (2019)
Hypoxia-induced interaction of filamin with Drp1 causes mitochondrial hyperfission-associated myocardial senescence
Akiyuki Nishimura et al.
SCIENCE SIGNALING (2018)
TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy
Tsukasa Shimauchi et al.
JCI INSIGHT (2017)
Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension
Akiyuki Nishimura et al.
SCIENCE SIGNALING (2016)
TRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling
Naoyuki Kitajima et al.
SCIENTIFIC REPORTS (2016)
Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension
Akiyuki Nishimura et al.
SCIENCE SIGNALING (2016)
Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy
Candace M. Adamo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Roles of TRP channels in the development of cardiac hypertrophy
Motohiro Nishida et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
Mechanism of action of T-705 against influenza virus
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity
J Gibo et al.
LABORATORY INVESTIGATION (2005)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)